XML 28 R17.htm IDEA: XBRL DOCUMENT v3.24.0.1
Other (Income) Expense
12 Months Ended
Dec. 31, 2023
Other Income and Expenses [Abstract]  
Other (Income) Expense

Note 6. Other (Income) Expense

 

 

 

 

 

 

 

 

 

(In millions)

 

2023

 

 

2022

 

 

2021

 

Non-service related pension and other postretirement benefits cost

 

$

148

 

 

$

178

 

 

$

92

 

Interest income on a favorable indirect tax ruling in Brazil

 

 

 

 

 

 

 

 

(48

)

Financing fees and financial instruments expense

 

 

59

 

 

 

40

 

 

 

39

 

Net foreign currency exchange (gains) losses

 

 

87

 

 

 

12

 

 

 

29

 

Interest income

 

 

(84

)

 

 

(34

)

 

 

(24

)

General and product liability expense - discontinued products

 

 

6

 

 

 

5

 

 

 

 

Royalty income

 

 

(30

)

 

 

(27

)

 

 

(24

)

Net (gains) losses on asset sales

 

 

(104

)

 

 

(122

)

 

 

(20

)

Transaction costs

 

 

 

 

 

 

 

 

40

 

Miscellaneous (income) expense

 

 

26

 

 

 

23

 

 

 

10

 

 

$

108

 

 

$

75

 

 

$

94

 

Non-service related pension and other postretirement benefits cost consists primarily of the interest cost, expected return on plan assets and amortization components of net periodic cost, as well as curtailments and settlements which are not related to rationalization plans. Non-service related pension and other postretirement benefits cost includes net pension settlement and

curtailment charges of $40 million, $124 million and $43 million in 2023, 2022 and 2021, respectively. For further information, refer to Note to the Consolidated Financial Statements No. 18, Pension, Other Postretirement Benefits and Savings Plans.

We, along with other companies, had previously filed various claims with the Brazilian tax authorities challenging the legality of the government's calculation of certain indirect taxes. In 2021, the Brazilian Supreme Court rendered a final ruling that was favorable to companies on the remaining open aspects of these claims. As a result of the ruling, we recorded a gain in CGS of $69 million and related interest income of $48 million in Other (Income) Expense.

Financing fees and financial instruments expense consists of commitment fees and charges incurred in connection with financing transactions, primarily due to accounts receivable factoring programs. Financing fees and financial instruments expense in 2021 included a $10 million charge for a commitment fee on a bridge term loan facility related to the Cooper Tire acquisition that was not utilized and was terminated upon the closing of the transaction.

Net foreign currency exchange (gains) losses include losses of $80 million, $19 million and $13 million related to the Argentine peso in 2023, 2022 and 2021, respectively, and a $13 million loss related to the Turkish lira in 2023.

Interest income includes interest income in Argentina of $44 million, $17 million and $8 million in 2023, 2022 and 2021, respectively.

Net gains on asset sales in 2023 primarily relate to gains on sale and leaseback transactions of $88 million, resulting in $99 million of cash proceeds. Sale and leaseback transactions included the sale and leaseback of a warehouse in Americas in the second quarter of 2023 and a retail location in Americas in the fourth quarter of 2023. A $59 million gain was recorded in the second quarter of 2023 related to the sale and leaseback transaction for the warehouse in Americas. Cash proceeds related to this transaction totaled $66 million. Leaseback terms for this location include a 5-year initial term with one 5-year renewal option. We have determined it is not probable that we will exercise this option. This transaction resulted in the recognition of Operating Lease Right-of-Use Assets totaling $24 million. The sale and leaseback transaction in the fourth quarter of 2023 for the retail location in Americas resulted in a gain of $23 million. Cash proceeds related to this transaction totaled $24 million. Leaseback terms for this location include a 5-year initial term. This transaction resulted in the recognition of Operating Lease Right-of-Use Assets totaling $7 million. The remainder of net gains on asset sales in 2023 primarily relate to the sale and exit of certain retail locations in Americas.

Net gains on asset sales in 2022 include a $95 million gain related to a sale and leaseback transaction of certain consumer and commercial retail locations in Americas. Cash proceeds related to this transaction totaled $108 million. Leaseback terms for all locations include a 15-year initial term with up to six 5-year renewal options. We determined at the inception of the leases that it was not probable that we would exercise any of the renewal options. The transaction resulted in the recognition of Operating Lease Right-of-Use Assets totaling $57 million. The remainder of net gains on asset sales in 2022 primarily relate to the sale and exit of certain retail locations in Americas. Net gains on asset sales in 2021 primarily relate to the sale of land in Hanau, Germany.

Transaction costs include legal, consulting and other expenses incurred by us in connection with the Cooper Tire acquisition.

Miscellaneous (income) expense in 2023 includes non-indemnified costs for product liability claims related to products manufactured by a formerly consolidated joint venture entity totaling $31 million and a $10 million loss related to the sale of a receivable in Argentina, partially offset by $5 million of income for the write-off of accumulated foreign currency translation related to our exited business in Russia. Miscellaneous (income) expense in 2023 also includes $11 million of income related to a favorable court decision setting aside a previous unfavorable verdict on intellectual property-related legal claims. The impact of that verdict and other fees of $15 million was recorded in miscellaneous (income) expense in 2022. Miscellaneous (income) expense in 2021 includes an insurance settlement gain of $10 million.

Other (Income) Expense also includes general and product liability expense - discontinued products, which consists of charges for claims against us related primarily to asbestos personal injury claims, net of probable insurance recoveries; and royalty income, which is derived primarily from licensing arrangements.